Argenica Therapeutics Ltd (agn) Logo

Argenica Therapeutics Ltd (AGN)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials
News

AGN ASX Chart

Snapshot

Argenica Therapeutics Limited (AGN) is into research and development of a neuroprotective therapeutic drug. The Company is developing novel neuroprotective therapeutics to reduce brain damage after stroke.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) +18.21%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 980 of 2,352
Sector Rank 83 of 230

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies PER / ACW / PIQ
EPS -$0.053
DPS $0.00
Book Value Per Share $0.109

Broker Consensus

AGN is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Nedlands WA 6009
Website www.argenica.com.au
Registry Link Market Services
Auditor RSM Australia Partners
Date Listed 11 Jun 2021

Upcoming Calendar (Forecasted)

Date Event
26/02/2025 Report (Interim)
27/08/2025 Report (Prelim)
27/08/2025 Report (Annual)

Former Company Names

  • Argenica Therapeutics Ltd has no former company names.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

AGN directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
14/08/24 Dianne Angus Issued 500,000 $0.275 $137,727 Issue of options
08/08/24 Elizabeth (Liddy) McCall Buy +318,182 $0.79 $251,363 Exercise of options
08/08/24 Elizabeth (Liddy) McCall Exercise 318,182 $0.79 $251,363 Exercise of options
08/08/24 Elizabeth (Liddy) McCall Cancelled 181,818 $0.825 $150,000 As advised by the company
08/08/24 Terrence (Terry) Budge Buy +318,182 $0.79 $251,363 Exercise of options
08/08/24 Terrence (Terry) Budge Exercise 318,182 $0.79 $251,363 Exercise of options
08/08/24 Terrence (Terry) Budge Cancelled 181,818 $1.00 $181,818 As advised by the company
08/08/24 Liz Dallimore Buy +1,590,909 $0.79 $1,256,818 Exercise of options
08/08/24 Liz Dallimore Exercise 1,590,909 $0.79 $1,256,818 Exercise of options
08/08/24 Liz Dallimore Cancelled 909,091 $0.825 $750,000 As advised by the company
05/06/24 Geoffrey (Geoff) Pocock Buy +294,239 $0.72 $211,852 Exercise of options
05/06/24 Geoffrey (Geoff) Pocock Exercise 294,239 $0.72 $211,852 Exercise of options
05/06/24 Geoffrey (Geoff) Pocock Cancelled 205,761 $0.729 $150,000 As advised by the company
30/11/22 Liz Dallimore Issued 2,000,000 $0.535 $1,070,000 Issued under employee share plan
14/06/22 Liz Dallimore Buy +10,916 $0.40 $4,366 On-market trade
14/06/22 Geoffrey (Geoff) Pocock Buy +27,000 $0.41 $11,070 On-market trade
10/06/22 Liz Dallimore Buy +39,084 $0.40 $15,633 On-market trade
10/06/22 Geoffrey (Geoff) Pocock Buy +32,690 $0.414 $13,532 On-market trade
25/02/22 Terrence (Terry) Budge Buy +32,520 $0.639 $20,786 On-market trade

Director Interests

The current holdings of AGN directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Mark Etherton 17/09/2024 0 N/A N/A N/A
Robert Black 17/09/2024 N/A 25,000 N/A N/A
Liz Dallimore 28/08/2024 N/A 1,640,909 2,000,000 N/A
Dianne Angus 28/08/2024 N/A N/A 500,000 N/A
Terrence (Terry) Budge 28/08/2024 N/A 805,702 N/A N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Aug 15, 2024.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Bond Street Custodians Limited <Lam1 D08047 A/C> 5,031,319 3.96%
Oofy Prosser Pty Ltd <Drones Family A/C> 4,708,929 3.70%
National Nominees Limited 4,382,545 3.45%
Mr Neil Donald Delroy <Ndd Investment A/C> 4,286,398 3.37%
J P Morgan Nominees Australia Pty Limited 3,652,225 2.87%
Perron Institute For Neurological And Translational Science Ltd 3,550,000 2.79%
Litis Super Pty Ltd <Jde Litis Super Fund A/C> 2,992,308 2.35%
University Of Western Australia 2,868,876 2.26%
Agati Pty Ltd 2,133,083 1.68%
Ms Helen Margaret Sewell 1,662,500 1.31%
Mrs Elizabeth Jane Dawson & Mr Lewis Macdonald Dawson <Dawson Family A/C> 1,640,909 1.29%
Arredo Pty Ltd 1,550,000 1.22%
Mr Gary Robert Wayne 1,545,952 1.22%
Xcel Capital Pty Ltd 1,382,500 1.09%
Citicorp Nominees Pty Limited 1,351,122 1.06%
Busso Holdings Pty Ltd <Bew A/C> 1,343,182 1.06%
Mr Bruno Philip Meloni <Bruno Meloni Family A/C> 1,252,000 0.98%
Pindan Investments Pty Ltd <Pindan Investment A/C> 1,185,332 0.93%
Oeneus Pty Ltd 1,106,746 0.87%
Mr Shane Hoehock Wee <Wee Family A/C> 1,100,000 0.87%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 193 581 321 803 186 2,084

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Insignia Financial Ltd 15/08/2024 6,274,450 5.07
Neil Delroy 15/08/2024 7,405,976 5.83

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
04-07-24 Insignia Financial Ltd 6,274,450 -- 5.07

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2024 $0.783 28 June
2023 $0.375 30 June
2022 $0.43 30 June
2021 $0.20 30 June
AGN Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.